Patents Represented by Attorney, Agent or Law Firm Barbara E. Johnson
-
Patent number: 8329142Abstract: Compounds, compositions and methods for the detection and diagnosis of Parkinson's disease. Derivative lycerophosphocholine (GPC) compounds are used as a detection and diagnostic aid to measure progression of Parkinson's disease by detecting GPC binding to ?-synuclein. Derivative CPG compounds including non-radioactive, paramagnetic, and radioactive derivatives of GPC are presented. These compounds possess similar binding properties to original GPC molecules and are useful in medical magnetic resonance imaging (MRI) and/or positron emission tomography (PET) applications. By employing these radiological techniques in conjunction with the compositions of the present invention, the detection, diagnosis and assessment of the progression of Parkinson's disease may be achieved.Type: GrantFiled: July 23, 2008Date of Patent: December 11, 2012Inventors: Jay W. Pettegrew, Richard J. McClure, Kanagasabai Panchalingam
-
Patent number: 8277315Abstract: A video game includes: (i) a graphic user interface that presents a user a simulation of real-life events; (ii) a content database containing a collection of actual photos and videos of real-life events; (iii) a simulation engine that, presents a plurality of possible actions to the user, receives a selection of at least one of the actions from the user, identifies at least one photo or video in the database that is associated with the user-selected action, and presents the user with a result in response to the selection, wherein the result includes the identified photo or video; (iv) a content update module that receives updated photo or video content from one or more content distributors, creates an association element for the updated content and an available action in the game, and includes the updated content and association element in the content database; and (v) a scoring module.Type: GrantFiled: March 1, 2007Date of Patent: October 2, 2012Assignee: Hybrid Learning Systems, Inc.Inventors: Asi Burak, Eric W. Brown, Eric Keylor, Victoria Webb, Wang-Ling Lin, Tim Sweeney, Ross Popoff
-
Patent number: 8147491Abstract: A clamp for an external fixation system includes a body having a bottom portion and semi-spherical top portion. The top portion has a threaded bore provided along a longitudinal axis: The clamp includes a clamp assembly having a base with a semi-spherical cavity and a lid positioned over the base to house at least one pin between the base and the lid. The base and the lid have a bore provided along a longitudinal axis thereof. A fastening member is provided that extends through the bore in the base and the lid of the clamp assembly and is secured within the threaded bore of the top portion of the body. The bores in the base and the lid have a diameter that is greater than the diameter of the fastening member.Type: GrantFiled: June 25, 2008Date of Patent: April 3, 2012Assignee: Vilex in Tennessee, Inc.Inventor: Abraham Lavi
-
Patent number: 8052875Abstract: An apparatus and method for continuous separation of magnetic particles from non-magnetic fluids including particular rods, magnetic fields and flow arrangements.Type: GrantFiled: January 4, 2010Date of Patent: November 8, 2011Assignee: EXPORTech Company, Inc.Inventors: Robin R. Oder, Russell E. Jamison
-
Patent number: 7989615Abstract: The invention is a method for isolating a desired plasmid DNA isoform, typically a supercoiled isoform, which includes the steps of obtaining a quantity of bioreactor produced plasmid DNA in liquid form for purification, and passing the plasmid DNA through an ultrafiltration membrane at a selected filtrate flux.Type: GrantFiled: July 9, 2008Date of Patent: August 2, 2011Assignee: The Penn State Research FoundationInventors: Andrew Lawrence Zydney, David Robert Latulippe
-
Patent number: 7960360Abstract: A class of antisense agents having a distributed guanidinium peptide nucleic acids (GPNA) backbone which has excellent uptake into mammalian cells, can bind to the target DNA or RNA in a highly sequence specific manner and can resist nucleases and proteases both outside and inside the cell(s) of interest. In one embodiment, either systemic or intratumoral administration of antisense Epidermal Growth Factor Receptor (“EGFR”) GPNA oligonucleotides is believed to downmodulate EGFR levels, thus in turn to reduce head and neck squamous cell carcinoma tumor growth, which has been confirmed to date both in vitro and in vivo.Type: GrantFiled: November 13, 2007Date of Patent: June 14, 2011Inventors: Jennifer Rubin Grandis, Sufi Mary Thomas, Danith H. Ly
-
Patent number: 7959681Abstract: The present invention provides a cannulated hemi-implant with a base and a threaded stem for fixing the stem of the implant within a medullary canal of a phalanx or other bone in the foot. The implant includes a tri-part head capable of both cutting bone and self-threading, with bone forming the medullary canal of a phalanx of a human foot. The present invention also provides a hand tool which engages and rotates the implant within the medullary canal of the phalanx. The present invention further provides a method of surgically implanting the implant in the medullary canal of the phalanx or other bone.Type: GrantFiled: August 22, 2006Date of Patent: June 14, 2011Assignee: Vilex in Tennessee, Inc.Inventor: Abraham Lavi
-
Patent number: 7932432Abstract: The present invention concerns a method for modifying the growth characteristics of a plant relative to corresponding wild type plants, comprising modifying expression in a plant of a seedy1 nucleic acid and/or modifying the level and/or activity in a plant of a seedy1 protein. The invention also concerns novel constructs and novel seedy1 nucleic acid and protein sequences.Type: GrantFiled: November 19, 2004Date of Patent: April 26, 2011Assignee: Crop Design N.V.Inventors: Valerie Frankard, Vladimir Mironov
-
Patent number: 7904283Abstract: The present invention provides for the first time a quantum mechanics-based method for scoring protein-ligand interactions and binding affinity predictions, using quantum mechanical Hamiltonians and/or a combined quantum mechanical/molecular mechanical approach, and Poisson-Boltzmann (PB)-based solvation methods. Also provided is a method for using quantum mechanics to describe the enthalpic and solvation effects of binding. The method comprises comparing the calculated binding affinities to experimental values in order to measure the success of the method. The methods disclosed herein may further be used to score protein and drug or protein and inhibitor interactions. The present method can predict the free energy of binding of protein-ligand complexes with high accuracy so as to enable lead optimization, thus serving as a powerful tool in computational drug design.Type: GrantFiled: May 12, 2004Date of Patent: March 8, 2011Assignee: The Penn State Research FoundationInventors: Kenneth M. Merz, Jr., Kaushik Raha
-
Patent number: 7902174Abstract: Chemical compounds, being the alkyl sulfate of sulfated saccharides, particularly, dextrin, dextran, and cyclodextrin, and pharmaceutical compositions containing these compounds. The compounds of the invention provide antiviral activity, particularly in the treatment and prevention of sexually-transmitted diseases. Methods of treating viral infection and preventing viral transmission include administration include administration of the compounds of the invention orally, topically, subcutaneously, by muscular injection, by intraperitoneal injection and by intravenous injection.Type: GrantFiled: February 6, 2009Date of Patent: March 8, 2011Inventor: Roger Hershline
-
Patent number: 7882676Abstract: A bracket for use with metal construction framing which is a generally planar construct having a first outer flange and a second outer flange, configured to form a recess between such flanges suitable to engage at least one face of a metal construction stud and to interlock with the stud via at least two non-longitudinal tabs.Type: GrantFiled: October 14, 2009Date of Patent: February 8, 2011Inventor: Jeffrey Thomas Ellis
-
Patent number: 7825293Abstract: The present invention relates to a method for improving plant growth by increasing activity of DP protein in shoot tissue. The invention also relates to transgenic plants having improved growth characteristics, due to increased expression of a DP nucleic acid specifically in shoot-tissue. The increased expression of the nucleic acid encoding a DP protein, according to the methods of the present invention, may be mediated by a shoot-tissue-specific promoter.Type: GrantFiled: February 17, 2005Date of Patent: November 2, 2010Assignee: CropDesign N.V.Inventors: Valerie Frankard, Christophe Reuzeau
-
Patent number: 7731097Abstract: A water saving device for us in a hot water system to recover an initial volume of cold water when a hot water tap is turned on. The device has an inlet for receiving water piped from a water heater, a primary outlet for delivering hot water to a tap, and a by-pass outlet through which any cooled water is diverted by a thermally actuated shuttle valve. The device also includes a secondary valve for closing off the by-pass outlet when the water pressure downstream of the primary outlet is high (such as when the down stream hot water delivery tap is closed and opening the by pass outlet when the water pressure downstream of the primary outlet is low, such as when the downstream hot water delivery tap is opened.Type: GrantFiled: July 15, 2005Date of Patent: June 8, 2010Assignee: Water Miser (Aust) Pty LtdInventors: Lindy Honeychurch, Ashley Thompson
-
Patent number: 7662793Abstract: A nucleic acid is provided comprising an expression cassette which includes transcription control sequences of a member of a class of Pol III-transcribed genes in which no transcribed portion of the Pol III gene is required for transcription of the gene. In the expression cassette, the transcribed 5? hairpin structure of the Pol III gene is deleted. The transcription control sequences are operably linked to a sequence of an EGFR gene in an antisense orientation suitable for decreasing expression of EGFR in the cell when transcribed. Lastly, a method for decreasing expression of EGFR in cells is provided that includes the step of contacting target cells either parenterally or directly into the tumor or tissue adjacent to the tumor cells with the nucleic acid of the present invention.Type: GrantFiled: March 12, 2003Date of Patent: February 16, 2010Assignee: University of Pittsburgh of the Commonwealth System of Higher EducationInventors: Yukai He, Jennifer R. Grandis, Leaf Huang
-
Patent number: 7659056Abstract: A method and apparatus for the detection of polymorphisms in a nucleic acid sample (e.g. blood, sperm, saliva, cells, . . . ). To enhance the efficiency and the reliability of the known methods (e.g. DGGE, SSCP and TGGE) the amplification process (e.g. PCR) preceding the actual detection step is performed in or on the polyacrylamide gel. Multiple gradients (of chemical denaturants, thermal denaturants and of porosity of the gel matrix) are used for the separation of DNA fragments, by zone electrophoresis on gel slabs or by capillary electrophoresis.Type: GrantFiled: October 23, 2000Date of Patent: February 9, 2010Assignee: Ingeny Holding B.V.Inventor: Gerrit Johannis De Vos
-
Patent number: 7658854Abstract: A magnetic separator vessel (1) for separating magnetic particles from non-magnetic fluid includes a separation chamber having an interior and exterior wall, a top and bottom portion; a magnet (3) having first and second poles (2) positioned adjacent to the exterior wall, wherein the first pole is substantially diametrically opposed to the second pole; a inlet port (5) is directed into the top portion of the separation chamber, wherein the inlet port (5) is positioned adjacent to one of the first and second poles (2), wherein the inlet port (5) is adapted to transfer a mixture into the separation chamber; an underflow port (6) in communication with the bottom portion, wherein the underflow port (6) is adapted to receive the magnetic particles; and an overflow port (9) in communication with the separation chamber, wherein the overflow port (9) is adapted to receive the non-magnetic fluid.Type: GrantFiled: October 8, 2004Date of Patent: February 9, 2010Assignee: EXPORTech Company, Inc.Inventors: Robin R. Oder, Russell E. Jamison
-
Patent number: 7621096Abstract: A bracket for use with metal construction framing which is a generally planar construct having a first outer flange and a second outer flange, configured to form a recess between such flanges suitable to engage at least one face of a metal construction stud and to interlock with the stud via at least two non-longitudinal tabs.Type: GrantFiled: April 10, 2008Date of Patent: November 24, 2009Inventor: Jeffrey Thomas Ellis
-
Patent number: 7563915Abstract: Methods for improved manufacture of green biodiesel focus on the selection and use of one or more solid metallic oxide base catalyst(s) selected from the group consisting of calcium oxide (CaO), calcium aluminum oxide (CaO—Al2O3), calcium titanate (CaTiO3), barium titanate (BaTiO3), magnesium aluminum oxide (MgO—Al2O3), zinc oxide (ZnO), copper (II) oxide (CuO), nickel oxide (NiO), manganese oxide (MnO), titanium oxide (TiO), vanadium oxide (VO), cobalt oxide (CoO), iron oxide (FeO), chromite (FeCr2O4), hydrotalcite (Mg6Al2(CO3)(OH)16.4(H2O), magnetite (Fe3O4), magnesium silicate and calcium silicate.Type: GrantFiled: May 29, 2007Date of Patent: July 21, 2009Assignee: The Penn State Research FoundationInventors: Jack Vincent Matson, Dheeban Chakravarthi Kannan
-
Patent number: 7495146Abstract: A wound dressing or bandage that provides a galvanic current for extended periods of time before having to change the dressing or bandage is addressed in the present invention. The present invention is directed to a galvanic current wound dressing having antimicrobial properties and to a method for treating a patient with the wound dressing.Type: GrantFiled: May 17, 2005Date of Patent: February 24, 2009Assignee: Vivo Ltd. PartnershipInventor: William E. Crisp
-
Patent number: 7427676Abstract: The invention provides several promoters isolated from Oryza sativa, which promoters are capable of driving and/or regulating the expression of an operably linked nucleic acid in a plant. The expression patterns of the promoters according to the invention have been studied in Oryza sativa and some of the promoters displayed specific activity in particular cells, tissues or organs of the plant, while others displayed constitutive expression throughout substantially the whole plant. Some promoters showed weak expression, while others were strongly active.Type: GrantFiled: February 4, 2004Date of Patent: September 23, 2008Assignee: Crop Design N.V.Inventors: Yves Hatzfeld, Willem Broekaert